Rapport Therapeutics, Inc. Common Stock (RAPP)

18.83

(-1.26%)

Long Term Debt Summary of Rapport Therapeutics, Inc. Common Stock

  • Rapport Therapeutics, Inc. Common Stock's latest annual long term debt in 2023 was 1.47 Million USD , down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock's latest quarterly long term debt in 2024 Q2 was 1.11 Million USD , down 0.0% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported annual long term debt of - USD in 2022, down 0.0% from previous year.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly long term debt of 1.29 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Rapport Therapeutics, Inc. Common Stock reported quarterly long term debt of 1.47 Million USD for 2023 FY, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Historical Annual Long Term Debt of Rapport Therapeutics, Inc. Common Stock (2023 - 2022)

Year Long Term Debt Long Term Debt Growth
2023 1.47 Million USD 0.0%
2022 - USD 0.0%

Peer Long Term Debt Comparison of Rapport Therapeutics, Inc. Common Stock

Name Long Term Debt Long Term Debt Difference